SGHT

Sight Sciences, Inc.

Sight Sciences, Inc. (SGHT) has 19 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Jul 6, 2026.

The most active filer is Chief Operating Officer Bauerlein Alison with 3 filings. Insiders have net sold $757K over the trailing 6 months.

  • Industry:Medical - Devices
  • CEO:Paul Badawi
  • Employees:216
  • HQ:Menlo Park, CA, US
  • IPO:2021-07-15

Insider Buying

$69K

reported purchases (SEC code P)

Insider Selling

$825K

reported sales (SEC code S)

Unique Insiders

7

in the rolling window

Market Cap

$286.2M

latest known value

Source
Sale$70KJul 6SEC ↗
Sale$37KJul 6SEC ↗
Badawi DavidFirst in 3 months
Sale$41KJul 6SEC ↗
Taylor BrentonFirst in 3 months
Sale$15KJul 6SEC ↗
Sale$130KJul 6SEC ↗
Badawi PaulFirst in 3 months
Sale$155KJul 6SEC ↗
Encrantz StaffanFirst filing
Purchase$69KJun 11SEC ↗
Sale$65KMay 19SEC ↗
Rodberg JamesFirst filing
Sale$26KApr 9SEC ↗
HAYDEN JEREMY B.First filing
Sale$49KApr 9SEC ↗
Taylor BrentonFirst filing
Sale$11KApr 3SEC ↗
Bauerlein AlisonFirst filing
Sale$90KApr 3SEC ↗
Badawi DavidFirst filing
Sale$28KApr 3SEC ↗
Badawi PaulFirst filing
Sale$108KApr 3SEC ↗

Related companies

Sight Sciences, Inc. is in the Healthcare sector.